跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
在 國立陽明交通大學研發優勢分析平台 搜尋內容
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
Increased risk of acute myocardial infarction in systemic sclerosis: A nationwide population-based study
Szu Ying Chu
, Yi Ju Chen
,
Chia Jen Liu
, Wei Cheng Tseng
,
Ming Wei Lin
, Chian Yaw Hwang
,
Chih Chiang Chen
, Ding Dar Lee
, Tzeng Ji Chen
, Yun Ting Chang
*
, Wen Jen Wang
, Han Nan Liu
*
此作品的通信作者
急重症醫學研究所
公共衛生研究所
醫學系皮膚學科
醫務管理研究所
研究成果
:
Article
›
同行評審
74
引文 斯高帕斯(Scopus)
總覽
指紋
指紋
深入研究「Increased risk of acute myocardial infarction in systemic sclerosis: A nationwide population-based study」主題。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
National Cohort Study
100%
Systemic Sclerosis
100%
Acute Myocardial Infarction
100%
Hazard Ratio
33%
Immunosuppressor
33%
Risk Factors
16%
Hypertension
8%
National Health Insurance Research Database (NHIRD)
8%
Autoimmune Disease
8%
Diabetes
8%
Comorbidity
8%
Epidemiological Study
8%
Adjusted Hazard Ratio
8%
Independent Risk Factors
8%
D-penicillamine
8%
Life-threatening
8%
Cox Proportional Hazards Model
8%
Methotrexate
8%
Ratio Factor
8%
Cyclophosphamide
8%
Incidence Rate
8%
Medical Illness
8%
Cyclosporine
8%
Hazard Risk
8%
Systemic Steroids
8%
Vasculopathy
8%
Systemic Control
8%
Myocardial Involvement
8%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Heart Infarction
100%
Systemic Sclerosis
100%
Immunosuppressive Agent
33%
Autoimmune Disease
8%
Penicillamine
8%
Methotrexate
8%
Cyclophosphamide
8%
Cohort Study
8%
Vascular Disease
8%
Azathioprine
8%
Ciclosporin
8%
Comorbidity
8%
Diseases
8%
Immunology and Microbiology
Systemic Scleroderma
100%
Immunosuppressive Drug
33%
Autoimmune Disease
8%
Cyclophosphamide
8%
Ciclosporin
8%
Methotrexate
8%
Azathioprine
8%
Comorbidity
8%
Penicillamine
8%